Bi-specific antibodies

Smithers Avanza Bioanalytical Services is aware of the unique bioanalytical and regulatory challenges inherent to the bioanalytical development of bi-specific antibody therapeutics and has performed bioanalytical analysis for  bi- and multi-specific antibodies at various stages of pre- and clinical development. Services include discovery bioassay, ADA assay, PK, Nab and ultra-sensitive biomarker services.